|
Item
|
Healthy
|
NeP (all)
|
PNeP
|
PHN
|
OFP
|
|---|
|
Neutrophils (%)
|
55.4 ± 9.1
|
58.6 ± 9.3
|
57.5 ± 10.1
|
57.3 ± 9.0
|
62.3 ± 8.5
|
|
Lymphocytes (%)
|
33.8 ± 8.1
|
29.2 ± 8.2
|
30.5 ± 7.9
|
28.3 ± 9.6
|
27.2 ± 8.1
|
|
CD4+ Counts × 1000
|
28.7 ± 7.3
|
33.5 ± 15.4
|
36.8 ± 18.8
|
30.3 ± 15.3
|
30.8 ± 2.9
|
|
CD4+ (%)
|
43.4 ± 9.9
|
47.5 ± 11.9
|
49.9 ± 12.6
|
44.3 ± 13.8
|
46.6 ± 8.0
|
|
TH1 (%)
|
9.7 ± 4.7
|
9.6 ± 4.1
|
10.9 ± 4.7
|
7.2 ± 3.1
|
9.3 ± 2.7
|
|
TH2 (%)
|
1.3 ± 1.2
|
1.5 ± 0.8
|
1.7 ± 0.7
|
0.9 ± 0.5
|
2.0 ± 0.9
|
|
TH17 (%)
|
1.3 ± 1.0
|
0.7 ± 0.4*
|
0.9 ± 0.4
|
0.4 ± 0.1*
|
0.8 ± 0.5
|
|
RORγT
|
2.7 ± 1.4
|
1.9 ± 1.0
|
1.8 ± 0.6*
|
1.9 ± 1.2*
|
2.2 ± 1.5
|
|
CD4+CD25high (%)
|
3.7 ± 0.7
|
5.4 ± 1.5*
|
5.1 ± 1.8*
|
5.0 ± 0.7*
|
6.4 ± 0.9*
|
|
Tregs (%)
|
2.0 ± 1.0
|
3.9 ± 1.3*
|
3.5 ± 1.1*
|
4.0 ± 1.9*
|
4.4 ± 0.9*
|
|
FoxP3
|
0.6 ± 0.2
|
1.2 ± 0.8*
|
1.0 ± 0.7*
|
1.3 ± 0.3*
|
1.4 ± 1.3*
|
- NeP (all): all patients suffering from neuropathic pain; PNeP: Peripheral neuropathic pain (symmetrical polyneuropathy/peripheral mononeuropathy); PHN: postherpetic neuralgia; OFP: orofacial pain; Results are expressed as mean ± standard deviation (SD), *P <0.05 versus healthy controls.
